EyePoint Pharmaceuticals: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 8, 2025, EyePoint, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, as amended, solely to change the Company’s name from “EyePoint Pharmaceuticals, Inc.” to “EyePoint, Inc.” The name change became effective on December 8, 2025. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference. In connection with the name change, the Company’s Board of Directors approved an amendment (the “By-laws Amendment”) to the Company’s by-laws, as amended (the “By-laws”), to reflect the change in the Company’s name, also effective December 8, 2025. No other changes were made to the By-laws. A copy of the By-laws Amendment is attached as Exhibit 3.2 hereto and is incorporated herein by reference. The Company’s common stock continues to trade on the Nasdaq Global Market under the ticker symbol “EYPT.” The name change does not affect the rights of the Company’s security holders, and the CUSIP number for Company’s common stock will continue to be 30233G209. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to Certificate of Incorporation. 3.2 Amendment No. 2 to the By-Laws. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EyePoint Pharmaceuticals, Inc. Date: December 8, 2025 By: /s/ George O. Elston George O. Elston Executive Vice President and Chief Financial Officer

EyePoint Pharmaceuticals: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits

Şirketle ilgili diğer haberler